Prabani

17 posts

Prabani

Prabani

@hiprabs

Consultant in Paediatric/Adolescent Oncology and Special Interest in Haematopoietic Stem Cell Transplant

Sri Lanka Katılım Ocak 2013
44 Takip Edilen27 Takipçiler
Prabani retweetledi
The Sri Lanka College of Oncologists
The Sri Lanka College of Oncologists@slconcology·
The Annual Academic Sessions organized by the SLCO 2024 were a great success! The event featured valuable insights and discussions, with strong collaboration across multidisciplinary teams. Thank you to all who contributed to making it such a memorable and impactful occasion!
The Sri Lanka College of Oncologists tweet mediaThe Sri Lanka College of Oncologists tweet mediaThe Sri Lanka College of Oncologists tweet media
English
0
1
3
105
Prabani retweetledi
The Sri Lanka College of Oncologists
The Sri Lanka College of Oncologists@slconcology·
The Young Oncologists' Forum of SLCO orchestrated highly successful regional sessions, marked by engaging discussions and invaluable networking opportunities for budding professionals in oncology.
The Sri Lanka College of Oncologists tweet mediaThe Sri Lanka College of Oncologists tweet mediaThe Sri Lanka College of Oncologists tweet mediaThe Sri Lanka College of Oncologists tweet media
English
0
2
3
79
Prabani retweetledi
The Sri Lanka College of Oncologists
The Sri Lanka College of Oncologists@slconcology·
We're excited to invite you to the Regional Sessions organized by the Young Oncologist's Forum of the Sri Lanka College of Oncologists, taking place in Kurunegala from July 5th to 6th 2024.
The Sri Lanka College of Oncologists tweet media
English
0
3
3
272
Prabani retweetledi
The Sri Lanka College of Oncologists
The Sri Lanka College of Oncologists@slconcology·
Join us at the CME program organized by the Sri Lanka College of Oncologists on Bowel Complications in a Neutropenic Patient on March 16th, 2024, at the Auditorium, NCISL.
The Sri Lanka College of Oncologists tweet media
English
0
1
1
108
Prabani retweetledi
Nuradh Joseph
Nuradh Joseph@nuradh·
I've used this widely in my practice due to resource constraints with excellent results.. #hypofractionation #headandneckcancer @slconcology @slcancer @Vimukthini
Prof Ananya💙 @achoud72.bsky.social@achoud72

HYPNO trial confirms non-inferiority of 55/20 to conventional fractionation with cisplatin👏🏽 As a registrar 55/20 was our SoC for #headandneck cancer. My favourite study today! #Moderatehypofractionation strikes again! #ASTRO23 @ASTRO_org @SorenBentzen @iaeaorg #optimalcare

English
0
4
6
654

Keşfet

@lionsclubs @Vimukthini @faro_asia @SlCancer @prasadabey @petric_primoz @RadOncTMC @slcancer